Glucose-lowering therapies, adequacy of metabolic control, and their relationship with comorbid depression in outpatients with type 2 diabetes in a tertiary hospital in Kenya

CF Frederick Otieno,1 Joseph E Kanu,1 Emma M Karari,1 Violet Okech-Helu,2 Mark D Joshi,1 Kenn Mutai2 1Department of Clinical Medicine and Therapeutics, University of Nairobi, 2Kenyatta National Hospital, Nairobi, Kenya Background: Depression and diabetes mellitus are important comorbid cond...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Otieno CFF, Kanu JE, Karari EM, Okech-Helu V, Joshi MD, Mutai K
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2017
Materias:	Specialties of internal medicine RC581-951
Acceso en línea:	https://doaj.org/article/8c93babe23594053bd9c2cc70b4e5055
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:8c93babe23594053bd9c2cc70b4e5055
record_format	dspace
spelling	oai:doaj.org-article:8c93babe23594053bd9c2cc70b4e50552021-12-02T08:21:38ZGlucose-lowering therapies, adequacy of metabolic control, and their relationship with comorbid depression in outpatients with type 2 diabetes in a tertiary hospital in Kenya1178-7007https://doaj.org/article/8c93babe23594053bd9c2cc70b4e50552017-04-01T00:00:00Zhttps://www.dovepress.com/glucose-lowering-therapies-adequacy-of-metabolic-control-and-their-rel-peer-reviewed-article-DMSOhttps://doaj.org/toc/1178-7007CF Frederick Otieno,1 Joseph E Kanu,1 Emma M Karari,1 Violet Okech-Helu,2 Mark D Joshi,1 Kenn Mutai2 1Department of Clinical Medicine and Therapeutics, University of Nairobi, 2Kenyatta National Hospital, Nairobi, Kenya Background: Depression and diabetes mellitus are important comorbid conditions with serious health consequences. When depression and diabetes are comorbid, depression negatively affects self-management activities of diabetes with serious consequences. Relationship between treatment regimens of diabetes, the adequacy of glycemic control, and occurrence of comorbid depression is not known among our patients.Patients and methods: This was a cross-sectional descriptive study at the outpatient diabetes clinic of the Kenyatta National Hospital where 220 ambulatory patients with type 2 diabetes on follow-up were systematically sampled. Sociodemographic data and clinical information were documented. The Patient Health Questionnaire-9 (PHQ-9) was used to assess depression. Ethylenediaminetetraacetic acid-anticoagulated blood was used for glycated hemoglobin (HbA1C) assay on automated system, COBAS INTEGRA machine.Results: Two hundred twenty patients with type 2 diabetes were enrolled. The prevalence of comorbid depression by PHQ-9 was 32.3% (95% confidence interval: 26.4%–38.6%). The majority, 69.5%, had poor glycemic control, HbA1C >7.0%, mean HbA1C was 8.9%±2.4%. Half, 50.4%, of the study subjects were on insulin-containing regimens. Over 8% (84.5%) of the participants with comorbid depression had poor glycemic control, which worsened with increasing severity of depression. There was significant correlation between comorbid depression and poor glycemic control, which is more consistent in the insulin-treated patients. However, patients on oral agents only, both with and without comorbid depression, were similar in their glycemic control.Conclusion: Among our type 2 diabetic population with comorbid depression, a large proportion had poor glycemic control, which worsened with increasing severity of depression. The insulin treatment increased the odds of comorbid depression and poor glycemic control in patients. It is justifiable to screen for comorbid depression in patients with type 2 diabetes who are in poor glycemic control, especially the insulin-treated, and then provide specific and appropriate interventions that are necessary to optimize their metabolic outcomes. Keywords: type 2 diabetes, comorbid depression, insulin therapy and poor glycemic controlOtieno CFFKanu JEKarari EMOkech-Helu VJoshi MDMutai KDove Medical PressarticleSpecialties of internal medicineRC581-951ENDiabetes, Metabolic Syndrome and Obesity: Targets and Therapy, Vol Volume 10, Pp 141-149 (2017)
institution	DOAJ
collection	DOAJ
language	EN
topic	Specialties of internal medicine RC581-951
spellingShingle	Specialties of internal medicine RC581-951 Otieno CFF Kanu JE Karari EM Okech-Helu V Joshi MD Mutai K Glucose-lowering therapies, adequacy of metabolic control, and their relationship with comorbid depression in outpatients with type 2 diabetes in a tertiary hospital in Kenya
description	CF Frederick Otieno,1 Joseph E Kanu,1 Emma M Karari,1 Violet Okech-Helu,2 Mark D Joshi,1 Kenn Mutai2 1Department of Clinical Medicine and Therapeutics, University of Nairobi, 2Kenyatta National Hospital, Nairobi, Kenya Background: Depression and diabetes mellitus are important comorbid conditions with serious health consequences. When depression and diabetes are comorbid, depression negatively affects self-management activities of diabetes with serious consequences. Relationship between treatment regimens of diabetes, the adequacy of glycemic control, and occurrence of comorbid depression is not known among our patients.Patients and methods: This was a cross-sectional descriptive study at the outpatient diabetes clinic of the Kenyatta National Hospital where 220 ambulatory patients with type 2 diabetes on follow-up were systematically sampled. Sociodemographic data and clinical information were documented. The Patient Health Questionnaire-9 (PHQ-9) was used to assess depression. Ethylenediaminetetraacetic acid-anticoagulated blood was used for glycated hemoglobin (HbA1C) assay on automated system, COBAS INTEGRA machine.Results: Two hundred twenty patients with type 2 diabetes were enrolled. The prevalence of comorbid depression by PHQ-9 was 32.3% (95% confidence interval: 26.4%–38.6%). The majority, 69.5%, had poor glycemic control, HbA1C >7.0%, mean HbA1C was 8.9%±2.4%. Half, 50.4%, of the study subjects were on insulin-containing regimens. Over 8% (84.5%) of the participants with comorbid depression had poor glycemic control, which worsened with increasing severity of depression. There was significant correlation between comorbid depression and poor glycemic control, which is more consistent in the insulin-treated patients. However, patients on oral agents only, both with and without comorbid depression, were similar in their glycemic control.Conclusion: Among our type 2 diabetic population with comorbid depression, a large proportion had poor glycemic control, which worsened with increasing severity of depression. The insulin treatment increased the odds of comorbid depression and poor glycemic control in patients. It is justifiable to screen for comorbid depression in patients with type 2 diabetes who are in poor glycemic control, especially the insulin-treated, and then provide specific and appropriate interventions that are necessary to optimize their metabolic outcomes. Keywords: type 2 diabetes, comorbid depression, insulin therapy and poor glycemic control
format	article
author	Otieno CFF Kanu JE Karari EM Okech-Helu V Joshi MD Mutai K
author_facet	Otieno CFF Kanu JE Karari EM Okech-Helu V Joshi MD Mutai K
author_sort	Otieno CFF
title	Glucose-lowering therapies, adequacy of metabolic control, and their relationship with comorbid depression in outpatients with type 2 diabetes in a tertiary hospital in Kenya
title_short	Glucose-lowering therapies, adequacy of metabolic control, and their relationship with comorbid depression in outpatients with type 2 diabetes in a tertiary hospital in Kenya
title_full	Glucose-lowering therapies, adequacy of metabolic control, and their relationship with comorbid depression in outpatients with type 2 diabetes in a tertiary hospital in Kenya
title_fullStr	Glucose-lowering therapies, adequacy of metabolic control, and their relationship with comorbid depression in outpatients with type 2 diabetes in a tertiary hospital in Kenya
title_full_unstemmed	Glucose-lowering therapies, adequacy of metabolic control, and their relationship with comorbid depression in outpatients with type 2 diabetes in a tertiary hospital in Kenya
title_sort	glucose-lowering therapies, adequacy of metabolic control, and their relationship with comorbid depression in outpatients with type 2 diabetes in a tertiary hospital in kenya
publisher	Dove Medical Press
publishDate	2017
url	https://doaj.org/article/8c93babe23594053bd9c2cc70b4e5055
work_keys_str_mv	AT otienocff glucoseloweringtherapiesadequacyofmetaboliccontrolandtheirrelationshipwithcomorbiddepressioninoutpatientswithtype2diabetesinatertiaryhospitalinkenya AT kanuje glucoseloweringtherapiesadequacyofmetaboliccontrolandtheirrelationshipwithcomorbiddepressioninoutpatientswithtype2diabetesinatertiaryhospitalinkenya AT karariem glucoseloweringtherapiesadequacyofmetaboliccontrolandtheirrelationshipwithcomorbiddepressioninoutpatientswithtype2diabetesinatertiaryhospitalinkenya AT okechheluv glucoseloweringtherapiesadequacyofmetaboliccontrolandtheirrelationshipwithcomorbiddepressioninoutpatientswithtype2diabetesinatertiaryhospitalinkenya AT joshimd glucoseloweringtherapiesadequacyofmetaboliccontrolandtheirrelationshipwithcomorbiddepressioninoutpatientswithtype2diabetesinatertiaryhospitalinkenya AT mutaik glucoseloweringtherapiesadequacyofmetaboliccontrolandtheirrelationshipwithcomorbiddepressioninoutpatientswithtype2diabetesinatertiaryhospitalinkenya
_version_	1718398555357446144

Glucose-lowering therapies, adequacy of metabolic control, and their relationship with comorbid depression in outpatients with type 2 diabetes in a tertiary hospital in Kenya

Ejemplares similares